GSS — Genetic Signatures Share News
0.000.00%
- AU$14.99m
- -AU$14.32m
- AU$21.36m
Brief: Genetic Signatures Announces A$30 Mln Capital Raising
Brief: Genetic Signatures Appoints Allison Rossiter As CEO
Brief: Genetic Signatures Says FDA Clearance For Gastrointestinal Parasite Detection Kit
Brief: Genetic Signatures Seeks Trading Halt
Brief: Genetic Signatures Says Decision To Cease Development Of US Respiratory Product
Brief: Genetic Signatures Says John Melki Stepped Down As CEO
Brief: Genetic Signatures Posts Qtrly Sales Of A$1.7 Mln
Brief: Genetic Signatures Says TGA Authorises Supply Of Updated Respiratory Detection Kit
Brief: Genetic Signatures Posts HY Loss Attributable Up 62% To A$10.5 Mln
Brief: Genetic Signatures Posts Sales (Unaudited) For Q2 Of Fy2024
Brief: Genetic Signatures Announces A$15.9M Capital Raising
Australia's Genetic Signatures hits nearly 5-1/2-year low on discounted capital raise
Brief: Genetic Signatures Ltd Seeks Trading Halt
Brief: Genetic Signatures Says Quarterly Sales Of A$1.6 Million Down 64%
Brief: Genetic Signatures Says 510(K) Application Submitted To US FDA
Brief: Genetic Signatures Says Influenza B Detection Expected To Impact On Quarter Sales
Brief: Genetic Signatures Posts Qtrly Sales Of A$4.5 Million Mln
Brief: Genetic Announces CFO appointment
Brief: Genetic Signatures Says Qtrly Sales Down 58% Q/Q